Published in Lab Invest on June 01, 1980
Oxidant injury of lung parenchymal cells. J Clin Invest (1981) 1.44
Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice. J Immunol (2009) 1.09
Lung cell oxidant injury. Enhancement of polymorphonuclear leukocyte-mediated cytotoxicity in lung cells exposed to sustained in vitro hyperoxia. J Clin Invest (1982) 1.06
Antioxidants preserve macrophage phagocytosis of Pseudomonas aeruginosa during hyperoxia. Free Radic Biol Med (2007) 0.96
The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Mol Med (2014) 0.84
Ascorbic Acid Attenuates Hyperoxia-Compromised Host Defense against Pulmonary Bacterial Infection. Am J Respir Cell Mol Biol (2016) 0.79
Antioxidants in neonatal lung disease. Arch Dis Child Fetal Neonatal Ed (1995) 0.79
Hyperoxia, HMGB1, and ventilator-associated pneumonia: reducing risk by practicing what we teach. Am J Respir Cell Mol Biol (2013) 0.75
Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc Natl Acad Sci U S A (1986) 5.12
Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc Natl Acad Sci U S A (1976) 3.74
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J Virol (1987) 3.58
Ethical consideration of incidental findings on adult brain MRI in research. Neurology (2004) 3.56
Whose death is it, anyway? Ann Intern Med (1996) 3.10
Initiating and withdrawing life support. Principles and practice in adult medicine. N Engl J Med (1988) 3.00
Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med (1988) 2.80
Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med (1990) 2.76
Necrotizing fasciitis. Chest (1996) 2.74
Rapid withdrawal of support. Chest (1995) 2.66
Pulmonary edema. 2. N Engl J Med (1973) 2.60
Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology (1987) 2.53
Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States. Chest (2000) 2.44
Overdiagnosis and overtreatment of pulmonary embolism: the emperor may have no clothes. Ann Intern Med (1977) 2.43
The diagnosis of pulmonary embolism. When will we ever learn? Chest (1995) 2.37
Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med (2000) 2.30
The Caenorhabditis elegans autosomal dominant polycystic kidney disease gene homologs lov-1 and pkd-2 act in the same pathway. Curr Biol (2001) 2.27
Ethical decision-making in critical care in Hong Kong. Crit Care Med (1998) 2.25
The management of chylothorax. Chest (1992) 2.24
Total eosinophil counts in the management of bronchial asthma. N Engl J Med (1975) 2.09
Reliability of the thermodilution method in the determination of cardiac output in clinical practice. Am Rev Respir Dis (1982) 2.07
Withdrawing life support: extubation and prolonged terminal weans are inappropriate. Crit Care Med (1996) 2.04
Inhalational anthrax: epidemiology, diagnosis, and management. Chest (1999) 1.97
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest (1984) 1.91
Pulmonary radiation injury. Chest (1997) 1.89
Thoracic electrical bioimpedance measurement of cardiac output--not ready for prime time. Crit Care Med (1993) 1.88
An analysis of platypnea-orthodeoxia syndrome including a "new" therapeutic approach. Chest (1997) 1.78
Pulmonary edema. 1. N Engl J Med (1973) 1.77
Speculations on neurogenic pulmonary edema (NPE). Am Rev Respir Dis (1976) 1.72
Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest (1986) 1.71
Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med (1997) 1.71
Noninvasive positive pressure ventilation for patients with terminal respiratory failure: the ethical and economic costs of delaying the inevitable are too great. Am J Crit Care (1994) 1.70
Prediction of readmissions after CABG using detailed follow-up data: the Israeli CABG Study (ISCAB) Med Care (1999) 1.62
Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant (1996) 1.60
Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis. Thorax (1991) 1.59
NMR structure of the calreticulin P-domain. Proc Natl Acad Sci U S A (2001) 1.58
Actinomyces odontolyticus thoracopulmonary infections. Two cases in lung and heart-lung transplant recipients and a review of the literature. Chest (1996) 1.58
Platypnea related to orthodeoxia caused by true vascular lung shunts. N Engl J Med (1976) 1.54
Thermophoresis of DNA determined by microfluidic fluorescence. Eur Phys J E Soft Matter (2004) 1.54
Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Respir Dis (1988) 1.54
The cult of the Swan-Ganz catheter. Overuse and abuse of pulmonary flow catheters. Ann Intern Med (1985) 1.53
Life-sustaining treatment for patients with AIDS. Chest (1989) 1.50
Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg (1989) 1.49
Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest (1996) 1.46
Sepsis therapy trials. Continued disappointment or reason for hope? JAMA (1994) 1.46
Pulmonary arteriovenous malformations: a critical update. Am Rev Respir Dis (1986) 1.45
Twenty-eight cases of human heart-lung transplantation. Lancet (1986) 1.44
Infectious complications of indwelling long-term central venous catheters. Chest (1990) 1.41
Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts. Chest (1996) 1.40
Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis (1991) 1.40
Regulation of neutrophil interleukin 8 gene expression and protein secretion by LPS, TNF-alpha, and IL-1 beta. J Cell Physiol (1993) 1.39
Care of the dying: an ethical and historical perspective. Crit Care Med (1992) 1.39
Combined heart and single-lung transplantation in complex congenital heart disease. Ann Thorac Surg (1998) 1.38
Acute cyanide poisoning complicated by lactic acidosis and pulmonary edema. Arch Intern Med (1977) 1.36
Pulmonary melioidosis. Chest (1995) 1.35
Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro. J Clin Invest (1985) 1.33
Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant (1996) 1.32
Enzymatic basis for bioenergetic differences of alveolar versus peritoneal macrophages and enzyme regulation by molecular O2. J Clin Invest (1977) 1.29
Anion and hydrogen ion distribution in human blood. J Lab Clin Med (1965) 1.27
Current trends in lung transplantation. Lobar transplantation and expanded use of single lungs. J Thorac Cardiovasc Surg (1992) 1.26
Platypnea (diffuse zone I phenomenon?). N Engl J Med (1969) 1.23
Extreme obesity associated with alveolar hypoventilation--a Pickwickian Syndrome. 1956. Obes Res (1994) 1.23
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC). Ann Oncol (2005) 1.23
Thermodiffusion of charged colloids: single-particle diffusion. Langmuir (2007) 1.22
Genetic testing and Alzheimer disease: has the time come? Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics & Society. Nat Med (1998) 1.17
Endothelial mosaic in Fuchs' dystrophy. A qualitative evaluation with the specular microscope. Arch Ophthalmol (1981) 1.16
The patient's response to medical futility. Arch Intern Med (2000) 1.16
Absence of HLA association or linkage for variations in sensitivity to the odor of androstenone. Immunogenetics (1982) 1.14
No correlation of focal contacts and close adhesion by comparing GFP-vinculin and fluorescence interference of Dil. Eur Biophys J (2001) 1.14
Indications for arterial blood gas analysis. Ann Intern Med (1986) 1.14
Capillary leak syndrome with pulmonary edema. Arch Intern Med (1972) 1.13
[15N,1H]/[13C,1H]-TROSY for simultaneous detection of backbone 15N-1H, aromatic 13C-1H and side-chain 15N-1H2 correlations in large proteins. J Biomol NMR (2000) 1.13
Single-patient randomized clinical trial. Opiates for intractable dyspnea. Chest (1986) 1.12
Sequence-specific NMR assignment of proteins by global fragment mapping with the program MAPPER. J Biomol NMR (2000) 1.12
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg (1996) 1.10
The chronically critically ill: to save or let die? Respir Care (1985) 1.09
Effect of the NADPH oxidase inhibitor apocynin on septic lung injury in guinea pigs. Am J Respir Crit Care Med (1994) 1.09
Clinical management conference. Interstitial lung disease in an elderly woman. West J Med (1982) 1.09
Pulmonary mechanics during pregnancy. J Clin Invest (1967) 1.08
Indices of hypoxemia in patients with acute respiratory distress syndrome: reliability, validity, and clinical usefulness. Crit Care Med (1997) 1.08
Attenuation of acute lung injury in septic guinea pigs by pentoxifylline. Am Rev Respir Dis (1988) 1.08
Effect of carbon monoxide exposure on human sleep and psychomotor performance. J Appl Physiol (1971) 1.07
Physiologic aspects of human heart-lung transplantation. Pulmonary function status of the post-transplanted lung. Chest (1984) 1.07
Lung cell oxidant injury. Enhancement of polymorphonuclear leukocyte-mediated cytotoxicity in lung cells exposed to sustained in vitro hyperoxia. J Clin Invest (1982) 1.06
PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis. Am J Pathol (2001) 1.05
Clinical heart-lung transplantation. Transplantation (1984) 1.05
Detection, quantitation and pathophysiology of lung "spiders". Trans Assoc Am Physicians (1975) 1.05
Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. Am Rev Respir Dis (1988) 1.04
The surgical management of severe gastroparesis in heart/lung transplant recipients. Chest (2000) 1.04
Methemoglobinemia from sniffing butyl nitrite. Ann Intern Med (1979) 1.04